Liraglutide : a new option in the management of type 2 diabetes

Milan K. Piya; Abd A. Tahrani; Anthony H. Barnett

doi:10.1002/fps.10

Liraglutide : a new option in the management of type 2 diabetes

Milan K. Piya
, Abd A. Tahrani
, Anthony H. Barnett

Research output: Contribution to journal › Article

Abstract

Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide and over 2.5 million by 2010 in the UK. Diabetes is a progressive disease which leads to macro and microvascular complications and reduced life expectancy. Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.

Original language	English
Pages (from-to)	6-12
Number of pages	7
Journal	Future Prescriber
Volume	9
Issue number	2
DOIs	https://doi.org/10.1002/fps.10
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

diabetes
microcirculation disorders
life expectancy

Access to Document

10.1002/fps.10

Cite this

@article{0068191071b64ccaabb970a52310f53f,

title = "Liraglutide : a new option in the management of type 2 diabetes",

abstract = "Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide and over 2.5 million by 2010 in the UK. Diabetes is a progressive disease which leads to macro and microvascular complications and reduced life expectancy. Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.",

keywords = "diabetes, microcirculation disorders, life expectancy",

author = "Piya, \{Milan K.\} and Tahrani, \{Abd A.\} and Barnett, \{Anthony H.\}",

year = "2008",

doi = "10.1002/fps.10",

language = "English",

volume = "9",

pages = "6--12",

journal = "Future Prescriber",

issn = "1468-9871",

publisher = "Wiley \& Sons",

number = "2",

}

TY - JOUR

T1 - Liraglutide : a new option in the management of type 2 diabetes

AU - Piya, Milan K.

AU - Tahrani, Abd A.

AU - Barnett, Anthony H.

PY - 2008

Y1 - 2008

N2 - Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide and over 2.5 million by 2010 in the UK. Diabetes is a progressive disease which leads to macro and microvascular complications and reduced life expectancy. Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.

AB - Type 2 diabetes mellitus (T2DM) is a global epidemic with an expected prevalence of 380 million in 2025 worldwide and over 2.5 million by 2010 in the UK. Diabetes is a progressive disease which leads to macro and microvascular complications and reduced life expectancy. Furthermore, diabetes-related complications have been shown to worsen patients' quality of life.

KW - diabetes

KW - microcirculation disorders

KW - life expectancy

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:43189

U2 - 10.1002/fps.10

DO - 10.1002/fps.10

M3 - Article

SN - 1468-9871

VL - 9

SP - 6

EP - 12

JO - Future Prescriber

JF - Future Prescriber

IS - 2

ER -

Liraglutide : a new option in the management of type 2 diabetes

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this